CORT
NASDAQ
$91.57
Corcept Therapeutics Inc (CORT)
Corcept Therapeutics Incorporated discovers, develops, and markets drugs for the treatment of severe metabolic, cancer, and psychiatric disorders in the United States. The company is headquartered in Menlo Park, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $106 (+15.76%)
Market Cap
$9.35B
PEG Ratio
0.81
Forward P/E
111.11
P/E Ratio
212.86
Price Chart
Valuation
Market Cap$9.35B
P/E212.86
Forward P/E111.11
PEG0.81
P/S12.63
P/B14.45
Profitability
Total Revenue (TTM)$769M
Gross Profit (TTM)$756M
EBITDA-$6.93M
Profit Margin-19.3%
Operating Margin-30.1%
EPS$0.42
Financial Health
Free Cash Flow Yield1.28%
Growth & Risk
EPS 5Y CAGR-8.23%
Revenue 5Y CAGR+17.73%
FCF 5Y CAGR-3.45%
Beta (5Y)1.32
Sharpe Ratio0.72